Literature DB >> 18285762

Methotrexate-associated mantle-cell lymphoma in an elderly man with myasthenia gravis.

Huy Tran1, Catherine Cheung, Devinder Gill, Ujjwal Dua, Jamie Nourse, Richard Boyle, Maher K Gandhi.   

Abstract

BACKGROUND: A 75-year-old man on methotrexate immunosuppression for myasthenia gravis presented with a 2-month history of lymphocytosis and bilateral inguinal adenopathy. There were no constitutional symptoms of fever, night sweats, or weight loss. INVESTIGATIONS: Physical examination, blood tests, flow cytometry, fluorescent in situ hybridization, immunoglobulin gene sequencing, viral load quantification by real-time polymerase chain reaction, excisional lymph-node biopsy, bone-marrow biopsy, tumor morphology and immunohistochemistry, sequential CT and PET scans. DIAGNOSIS: Methotrexate-associated mantle-cell lymphoma. MANAGEMENT: Cessation of methotrexate, anthracycline-based combination chemo-immunotherapy, and maintenance rituximab.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18285762     DOI: 10.1038/ncponc1071

Source DB:  PubMed          Journal:  Nat Clin Pract Oncol        ISSN: 1743-4254


  1 in total

1.  A methotrexate-associated lymphoproliferative disorder expressing CD10 and BCL6 with the IGH/CCND1 translocation.

Authors:  Hiroo Katsuya; Haruna Kizuka-Sano; Masako Yokoo; Keisuke Kidoguchi; Kyosuke Yamaguchi; Atsujiro Nishioka; Hiroshi Ureshino; Yasushi Kubota; Toshihiko Ando; Shinji Naito; Koichi Ohshima; Shinya Kimura
Journal:  Ann Hematol       Date:  2020-08-26       Impact factor: 3.673

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.